Format

Send to

Choose Destination
Dermatol Ther. 2018 Sep;31(5):e12686. doi: 10.1111/dth.12686. Epub 2018 Aug 28.

Minoxidil in the treatment of androgenetic alopecia.

Author information

1
Applied Biology, Inc., Irvine, California.

Abstract

The National Institutes of Health (US NIH, 2018) estimates that in the US approximately 50 million men and 30 million women suffer from AGA (also known as pattern hair loss). Minoxidil is the only topical drug for the treatment of both female and male pattern hair loss. In the US, minoxidil is approved over-the-counter (OTC) at a maximum concentration of 5%. In this review, we summarize the findings of the pivotal studies used in support of the drug's approval as well as recent discoveries and novel developments in the use of minoxidil for the treatment of AGA.

KEYWORDS:

alopecia; hair disorders; minoxidil

PMID:
30155952
DOI:
10.1111/dth.12686

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center